Alcohol abuse, vitamin B12 deficiency, kidney disease, infections, and physical trauma each contribute their own share
The Bigger Picture: Food as Metabolic Medicine The conversation around GLP-1 drugs has done something genuinely valuable: it has reframed weight management as a metabolic and hormonal challenge rather than a failure of willpower
These findings highlight the need for further studies to evaluate the effects of Glucagon-like peptide-1 receptor agonists on sleep regulation and the neurophysiological consequences of these agents
In the latest batch of warning letters to GLP manufacturers, the agency cited Prime Sciences, Lovega, Gram Peptides, FormPour, Guangzhou Huli Technology, Mile High Compounds, and PekCura Labs for marketing their products without FDA approval
Eur J Clin Pharmacol 1992, 43(6):667669
Given Medicares predicament across the pond, theyre unlikely to oblige